Nearly 1 million Medicare Advantage members face plan shutdowns from providers like UnitedHealth and Humana, risking loss of current coverage. While this reduces insurer costs and improves margins, affected members must act by December 7 to secure Medigap policies during a guaranteed-issue window, preserving coverage without health-based denial. Choosing new plans hastily may forfeit this right, impacting future costs and access. The upcoming Q3 results on October 13 will reveal if insurers' financial repairs hold.
As Medicare Advantage plans face shutdowns, investors are watching key health insurers closely. On Pluang, UnitedHealth Group (UNH) trades at USD 380.64, up 1.15% as of October 8, 2026, while Humana (HUM) is at USD 406.56, rising 0.56%. These moves come ahead of Q3 earnings, with UnitedHealth holding a market cap of $337.78 billion and Humana $48.54 billion, reflecting steady interest despite the sector's challenges.
UnitedHealth Group's stock has risen from $300 to around $440-$450, reflecting a recovery in margins and key business areas like Medicare Advantage and Optum Health. However, the current valuation leaves little room for safety, as the market already ...
UnitedHealth Group (UNH) is rated a Buy as its fundamentals improve and its price-to-earnings ratio hits a decade low at 19.95, despite being cheaper than peers. Key focus areas for Q3 include commercial cost trends, star ratings, cash flow guidance,...
